175 related articles for article (PubMed ID: 17318442)
1. A pharmacokinetic/pharmacodynamic approach to predict total prednisolone concentrations in human plasma.
Xu J; Winkler J; Derendorf H
J Pharmacokinet Pharmacodyn; 2007 Jun; 34(3):355-72. PubMed ID: 17318442
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics of oral prednisone and cortisol suppression in normal women.
Meno-Tetang GM; Blum RA; Schwartz KE; Jusko WJ
J Clin Pharmacol; 2001 Nov; 41(11):1195-205. PubMed ID: 11697752
[TBL] [Abstract][Full Text] [Related]
3. Physiologically Based Pharmacokinetic Modeling Involving Nonlinear Plasma and Tissue Binding: Application to Prednisolone and Prednisone in Rats.
Li X; DuBois DC; Almon RR; Jusko WJ
J Pharmacol Exp Ther; 2020 Nov; 375(2):385-396. PubMed ID: 32883831
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the impact of dosing time on the pharmacokinetics/pharmacodynamics of prednisolone.
Xu J; Winkler J; Sabarinath SN; Derendorf H
AAPS J; 2008 Jun; 10(2):331-41. PubMed ID: 18581240
[TBL] [Abstract][Full Text] [Related]
5. The non-linear pharmacokinetics of prednisone and prednisolone. III. Experiments using the rabbit as an animal model.
Ferry JJ; Wagner JG
Biopharm Drug Dispos; 1988; 9(4):363-76. PubMed ID: 3207856
[TBL] [Abstract][Full Text] [Related]
6. Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration.
Center SA; Randolph JF; Warner KL; Simpson KW; Rishniw M
Res Vet Sci; 2013 Aug; 95(1):225-30. PubMed ID: 23473553
[TBL] [Abstract][Full Text] [Related]
7. Effect of the anti-inflammatory agent tenidap on the pharmacokinetics and pharmacodynamics of prednisolone.
Garg V; Blum R; Wilner KD; Jusko WJ
J Clin Pharmacol; 1992 Mar; 32(3):222-30. PubMed ID: 1564126
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of prednisone and prednisolone in a case of hypothyroidism: effect of replacement therapy.
Bergamaschi S; Rusconi R; Gervasoni M; Rigamonti AE; Cella S; Bareggi SR
Steroids; 2005 Oct; 70(11):787-9. PubMed ID: 16045952
[TBL] [Abstract][Full Text] [Related]
9. Free prednisolone pharmacokinetics predicted from total concentrations in patients with inflammatory - immunonologic conditions.
Mangin O; Zheng Y; Bouazza N; Foissac F; Benaboud S; Lui G; Hirt D; Mouthon L; Tréluyer JM; Urien S
Fundam Clin Pharmacol; 2020 Apr; 34(2):270-278. PubMed ID: 31625621
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of prednisolone and endogenous cortisol suppression in the elderly.
Stuck AE; Frey BM; Frey FJ
Clin Pharmacol Ther; 1988 Apr; 43(4):354-62. PubMed ID: 3356080
[TBL] [Abstract][Full Text] [Related]
11. Lack of pharmacokinetic interaction between St. John's wort and prednisone.
Bell EC; Ravis WR; Chan HM; Lin YJ
Ann Pharmacother; 2007 Nov; 41(11):1819-24. PubMed ID: 17925494
[TBL] [Abstract][Full Text] [Related]
12. Prednisone per os is likely to have limited efficacy in horses.
Peroni DL; Stanley S; Kollias-Baker C; Robinson NE
Equine Vet J; 2002 May; 34(3):283-7. PubMed ID: 12108748
[TBL] [Abstract][Full Text] [Related]
13. A pharmacokinetic comparison of two oral liquid glucocorticoid formulations.
Kamada AK; Wiener MB; LaVallee NM; Scott MB; Selner JC; Szefler SJ
Pharmacotherapy; 1997; 17(2):353-6. PubMed ID: 9085328
[TBL] [Abstract][Full Text] [Related]
14. Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats.
Huang ML; Jusko WJ
J Pharmacokinet Biopharm; 1990 Oct; 18(5):401-21. PubMed ID: 2266496
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of plasma prednisolone, prednisone, and cortisol levels by high-performance liquid chromatography.
Majid O; Akhlaghi F; Lee T; Holt DW; Trull A
Ther Drug Monit; 2001 Apr; 23(2):163-8. PubMed ID: 11294518
[TBL] [Abstract][Full Text] [Related]
16. Monitoring prednisolone and prednisone in saliva: a population pharmacokinetic approach in healthy volunteers.
Teeninga N; Guan Z; Freijer J; Ruiter AF; Ackermans MT; Kist-van Holthe JE; van Gelder T; Nauta J
Ther Drug Monit; 2013 Aug; 35(4):485-92. PubMed ID: 23783167
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of total and unbound prednisone and prednisolone in stable kidney transplant recipients with diabetes mellitus.
Ionita IA; Ogasawara K; Gohh RY; Akhlaghi F
Ther Drug Monit; 2014 Aug; 36(4):448-55. PubMed ID: 24452065
[TBL] [Abstract][Full Text] [Related]
18. [Comparative serum pharmacokinetics of prednisone and prednisolone methylsulfobenzoate after oral administration].
Brion N; Pibarot ML; Atienza P; Robin P; Carbon C
Presse Med; 1988 Apr; 17(12):569-71. PubMed ID: 2967477
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability and reversible metabolism of prednisone and prednisolone in man.
Garg V; Jusko WJ
Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.
Bergmann TK; Barraclough KA; Lee KJ; Staatz CE
Clin Pharmacokinet; 2012 Nov; 51(11):711-41. PubMed ID: 23018468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
